New policies to address the global burden of childhood cancers
Open accessAbstract
Childhood cancer is a major global health issue. Every year, almost 100 000 children die from cancer before the age of 15 years, more than 90% of them in resource-limited countries. Here, we review the key policy issues for the delivery of better care, research, and education of professionals and patients. We present a key list of time-limited proposals focusing on change to health systems and research and development. These include sector and system reforms to make care affordable to all, policies to promote growth of civil society around both cancer and Millennium Development Goals, major improvements to public health services (particularly the introduction of national cancer plans), improved career development, and increased remuneration of specialist health-care workers and government support for childhood cancer registries. Research and development proposals focus on sustainable funding, the establishment of more research networks, and clinical research specifically targeted at the needs of low-income and middle-income countries. Finally, we present proposals to address the need for clinical trial innovation, the complex dichotomy of regulations, and the threats to the availability of data for childhood cancers.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cancer kills more than 100,000 children each year, mainly in low- and middle-income countries, where access to health services is often poor and treatment abandonment is a major problem.
“Cancer kills more than 100,000 children every year, mainly in low- and middle-income countries,93 where access to health services is often poor, and abandonment of treatment is a major problem.94,95”
The citation lists haven’t been fetched yet
References 57 · Cited by 121
- Authors
- Sullivan, R., Kowalczyk, J. R., Agarwal, B., Ladenstein, R., Fitzgerald, E., Barr, R., Steliarova-Foucher, E., Magrath, I., Howard, S. C., Kruger, M., Valsecchi, M. G., Biondi, A., Grundy, P., Smith, M. A., Adamson, P., Vassal, G., & Pritchard-Jones, K.
- Affiliations
- Kings Health Partners (GB)
- Medical University of Lublin (PL)
- Bai Jerbai Wadia Hospital for Children (IN)
- St Anna Children's Hospital (AT)
- European CanCer Organisation (BE)
- McMaster University (CA)
- International Network for Cancer Treatment and Research (BE)
- St. Jude Children's Research Hospital (US)
- Stellenbosch University (ZA)
- University of Milano-Bicocca (IT)
- Alberta Health Services (CA)
- National Institutes of Health (US)
- Children's Hospital of Philadelphia (US)
- Institut Gustave Roussy (FR)
- Corresponding author
- Sullivan, Richard
- ORCID
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 14
- Issue
- 3
- Pages
- e125-e135
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2163398618
- Cited by
- 121
- References
- 57
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 6 · 2020: 10 · 2019: 7 · 2018: 14 · 2017: 7 · 2016: 8 · 2015: 13 · 2014: 13 · 2013: 13
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Keywords
- childhood cancer, global health policy, health care reform, access to cancer care, resource-poor countries, National Cancer Plan, cancer registry, health workforce remuneration, research funding, clinical trial regulation, data availability, Millennium Development Goals, civil society
- MeSH terms
- Adolescent, Child, Clinical Trials as Topic, Government, Health Policy, Humans, Neoplasms, Research, Developed Countries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review